Neutra Corp. (OTCBB: NTRR) is preparing to test the effects of its
unique Bio-Energy infusion on two new powerful ingredients soon to be
found in the company’s Pure Plus Weight Loss supplement.
The new Dr. Oz-recommended weight-loss ingredients, African Mango and
Raspberry Ketone, are potent organic compounds shown to help boost
metabolism and burn fat naturally.
At the basic level, raspberry ketones increase the body’s core
temperature, which enhances the body’s ability to burn fat. African
mango helps reduce appetite, melt fat deposits, increase energy and
regulate the efficiency of leptin, a protein hormone that interacts with
areas of the brain that control hunger and signal the body that it has
had enough to eat.
Part of NTRR’s commitment to holistic wellness, the Bio-Energy infusion
is an all-natural process developed to modify substances on the
subatomic level, enhancing the efficiency and potency of beneficial
By infusing the supplement’s ingredients with Bio-Energy (also known as
Quantum Energy), NTRR aims to turbocharge the natural benefits of
African mango and raspberry ketone. The company expects to begin testing
different formulations later this week.
Neutra Corp. is developing Pure Plus and other new products to compete
in the fast-growing nutraceuticals industry alongside Herbalife Ltd.
(NYSE: HLF), Vitamin Shoppe (NYSE: VSI), Nutraceutical International
Corp. (NASDAQ: NUTR) and Schiff Nutrition International Inc. (NYSE: WNI).
is a healthy lifestyle company that specializes in the development and
marketing of nutritional supplements, nutrient boosters, herbal remedies
and other natural wellness solutions. The company is currently working
to produce a full range of products to address every component of a
healthy lifestyle, including muscle building, weight loss and general
wellness through a daily nutrition regimen. For investing information
and performance data, please visit www.neutracorp.com/investors.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act
of 1995: This news release contains forward-looking information within
the meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended,
including statements that include the words "believes," "expects,"
"anticipate" or similar expressions. Such forward-looking statements
involve known and unknown risks, uncertainties and other factors that
may cause the actual results, performance or achievements of the company
to differ materially from those expressed or implied by such
forward-looking statements. In addition, description of anyone's past
success, either financial or strategic, is no guarantee of future
success. This news release speaks as of the date first set forth above
and the company assumes no responsibility to update the information
included herein for events occurring after the date hereof.